Asundexian (also known as BAY2433334 ... which are thought to be out in front the in race to bring an oral FXIa inhibitor to market with their milvexian candidate. The promise of the new class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback